An optimal mRNA marker for OSNA (one-step nucleic acid amplification) based lymph node metastasis detection in colorectal cancer patients

Japanese Journal of Clinical Oncology

Volumn 43, Issue 3, 2013, Pages 264-270

  Yamamoto, Noriko ^a   Daito, Motonari ^b   Hiyama, Kayo ^b   Ding, Junyi ^b   Nakabayashi, Kadzuki ^b   Otomo, Yasuhiro ^b   Tsujimoto, Masahiko ^c   Matsuura, Nariaki ^d   Kato, Yo ^a  

^a CANCER INSTITUTE   (Japan)

^b SYSMEX CORPORATION   (Japan)

^c OSAKA POLICE HOSPITAL   (Japan)

^d OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Colorectal cancer; Cytokeratin 19; Lymph node metastasis; OSNA

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; CARRIER PROTEIN; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYTOKERATIN 19; CYTOKERATIN 20; FXYD DOMAIN CONTAINING ION TRANSPORT REGULATOR 3; MESSENGER RNA; MUCIN; MUCIN 11; MUCIN 12; MUCIN 13; MUCIN 2; UNCLASSIFIED DRUG;

ARTICLE; CANCER PATIENT; COLORECTAL CANCER; CONTROLLED STUDY; DATA BASE; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; EXPRESSED SEQUENCE TAG; GENE EXPRESSION; GENE SEQUENCE; GENETIC MARKER; GENETIC SCREENING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; NUCLEIC ACID AMPLIFICATION; ONE STEP NUCLEIC ACID AMPLIFICATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; KERATIN-19; KERATIN-20; LYMPHATIC METASTASIS; MALE; NUCLEIC ACID AMPLIFICATION TECHNIQUES; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 84874806694     PISSN: 03682811     EISSN: 14653621     Source Type: Journal    
DOI: 10.1093/jjco/hys227     Document Type: Article

References (40)

1. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 2004;96:1420-5.
2. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst 2007;99:433-41.
3. Cutait R, Alves VA, Lopes LC, et al. Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins. Dis Colon Rectum 1991;34:917-20.
4. Greenson JK, Martin EWJ. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival. Cancer 1994;73:563-9.
5. Jeffers MD, Toner M. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 1994;172:183-7.
6. Sasaki M, Hatakeyama K. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in 'node-negative' colorectal cancer. J Gastroenterol 1997;32:758-64.
7. Sirop S, Kanaan M, Korant A, et al. Detection and prognostic impact of micrometastasis in colorectal cancer. J Surg Oncol 2011;1:534-7.
8. Noura S, Monden M. Immunohistochemical assessment of localization and frequency of micrometastases in lymph nodes of colorectal cancer. Clin Cancer Res 2002;8:759-67.
9. Tsujimoto M, Nakabayashi K, Yoshidome K, et al. One-step nucleic acid amplification (OSNA) for intraoperative detection of lymph node metastasis in breast cancer patients. Clin Cancer Res 2007;13:4807-16.
10. Visser M, Jiwa M, Horstman A, et al. Intra-operative rapid diagnostic method based on CK19 mRNA expression for the detection of lymph node metastases in breast cancer. Int J Cancer 2008;122:2562-7.
11. Schem C, Maass N, Bauerschlag DO, et al. One-step nucleic acid amplification-a molecular method for the detection of lymph node metastases in breast cancer patients; results of the German study group. Virchows Arch 2009;454:203-10.
12. Tamaki Y, Akiyama F, Iwase T, et al. Molecular detection of lymph node metastases in breast cancer patients: results of a multicenter trial using the one-step nucleic acid amplification assay. Clin Cancer Res 2009;15:2879-84.
13. Snook KL, Layer GT, Jackson PA, et al.; for the OSNA Study Group. Multicentre evaluation of intraoperative molecular analysis of sentinel lymph nodes in breast carcinoma. Br J Surg 2010;98:527-35.
14. Feldman S, Krishnamurthy S, Gillanders W, et al.; US One Step Nucleic Acid Amplification Clinical Study Group. A novel automated assay for the rapid identification of metastatic breast carcinoma in sentinel lymph nodes. Cancer 2011;117:2599-607.
15. Osako T, Iwase T, Kimura K, et al. Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology. Cancer 2011;117:4365-74.
16. Bernet L, Cano R, Martinez M, et al. Diagnosis of the sentinel lymph node in breast cancer: a reproducible molecular method: a multicentric Spanish study. Histopathology 2011;58:863-9.
17. Frère-Belda MA, Bats AS, Gillaizeau F, et al. Diagnostic performance of one-step nucleic acid amplification for intraoperative sentinel node metastasis detection in breast cancer patients. Int J Cancer 2012;130:2377-86.
18. Yaguchi Y, Sugasawa H, Tsujimoto H, et al. One-step nucleic acid amplification (OSNA) for the application of sentinel node concept in gastric cancer. Ann Surg Oncol 2011;18:2289-96.
19. Yamamoto H, Sekimoto M, Oya M, et al. OSNA-based novel molecular testing for lymph node metastases in colorectal cancer patients: results from a Multicenter Clinical Performance Study in Japan. Ann Surg Oncol 2011;18:1891-8.
20. Taniyama K, Motoshita J, Sakane J, et al. Combination analysis of a whole lymph node by one-step nucleic acid amplification and histology for intraoperative detection of micrometastasis. Pathobiology 2006;73:183-91.
21. Schmitt AO, Specht T, Beckmann G, et al. Exhaustive mining of EST libraries for genes differentially expressed in normal and tumour tissues. Nucleic Acids Res 1999;27:4251-60.
22. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-8.
23. Notomi T, Okayama H, Masubuchi H, et al. Loop-mediated isothermal amplification of DNA. Nucleic Acids Res 2000;28:E63.
24. Mori Y, Nagamine K, Tomita N, Notomi T. Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation. Biochem Biophys Res Commun 2001;289:150-4.
25. Nagamine K, Hase T, Notomi T. Accelerated reaction by loop-mediated isothermal amplification using loop primers. Mol Cell Probes 2002;16:223-9.
26. Nordgård O, Oltedal S, Kørner H, et al. The potential of cytokeratin 20 and mucin 2 mRNA as metastasis markers in regional lymph nodes of colon cancer patients investigated by quantitative RT-PCR. Int J Colorectal Dis 2009;24:261-8.
27. D'Armento G, Daniele L, Mariani S, et al. Added value of combined gene and protein expression of CK20 and CEA in non-macroscopically involved lymph nodes of colorectal cancer. Int J Surg Pathol 2009;17:93-8.
28. Bustin SA, Siddiqi S, Ahmed S, Hands R, Dorudi S. Quantification of cytokeratin 20, carcinoembryonic antigen and guanylyl cyclase C mRNA levels in lymph nodes may not predict treatment failure in colorectal cancer patients. Int J Cancer 2004;108:412-7.
29. Oberg AN, Lindmark GE, Israelsson AC, Hammarström SG, Hammarstroöm ML. Detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR for CEA and CK20 mRNAs. Int J Cancer 2004;111:1-10.
30. Ohlsson L, Hammarstroöm ML, Israelsson A, et al. Biomarker selection for detection of occult tumour cells in lymph nodes of colorectal cancer patients using real-time quantitative RT-PCR. Br J Cancer 2006;95:218-25.
31. Gunn J, Wright PA. Detection of micrometastases in colorectal cancer patients by K19 and K20 reverse-transcription polymerase chain reaction. Lab Invest 1996;75:611-6.
32. Zweig MH, Broste SK, Reinhart RA. ROC curve analysis: an example showing the relationships among serum lipid and apolipoprotein concentrations in identifying patients with coronary artery disease. Clin Chem 1992;38:1425-8.
33. Xi L, Gooding W, McCarty K, Godfrey TE, Hughes SJ. Identification of mRNA markers for molecular staging of lymph nodes in colorectal cancer. Clin Chem 2006;52:520-3.
34. Lassmann S, Bauer M, Rosenberg R, et al. Identification of occult tumor cells in node negative lymph nodes of colorectal cancer patients by cytokeratin 20 gene and protein expression. Int J Colorectal Dis 2004;19:87-94.
35. Lotspeich E, Schoene M, Gerngross H, et al. Detection of disseminated tumor cells in the lymph nodes of colorectal cancer patients using a real-time polymerase chain reaction assay. Langenbecks Arch Surg 2007;392:559-66.
36. Ichikawa Y, Ishikawa T, Momiyama N, et al. Detection of regional lymph node metastases in colon cancer by using RT-PCR for matrix metalloproteinase 7, matrilysin. Clin Exp Metastasis 1998;16:3-8.
37. Widegren E, OnnesjöS, Arbman G, et al. Expression of FXYD3 protein in relation to biological and clinicopathological variables in colorectal cancers. Chemotherapy 2009;55:407-13.
38. Walsh MD, Young JP, Leggett BA, Williams SH, Jass JR, McGuckin MA. The MUC13 cell surface mucin is highly expressed by human colorectal carcinomas. Hum Pathol 2007;38:883-92.
39. Ruud P, Fodstad O, Hovig E. Identification of a novel cytokeratin 19 pseudogene that may interfere with reverse transcriptase-polymerase chain reaction assays used to detect micrometastatic tumor cells. Int J Cancer 1999;80:119-25.
40. Croner RS, Schellerer V, Demund H, et al. One step nucleic acid amplification (OSNA)-a new method for lymph node staging in colorectal carcinomas. J Transl Med 2010;6:83-9.